Form 4 for ASTH Astrana Health, Inc.
Accepted 2023-12-04 00:00:00 ET · period of report 2023-11-30 · accession 0001104659-23-123379 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-04 | 2023-11-30 | ASTH | Vong John | CAO | F - Tax | $33.23 | -65 | 4,901 | -1% | -$2,160 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-30 | F | D | 65 | $33.23 | 4,901 | D | — | — | (F1) This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award that vested on November 30, 2023. (F2) Includes 4,159 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares vest on each of July 11, 2024 and July 11, 2025 and 945 shares vest on July 11, 2026; (ii) 570 shares, which vest in three equal annual installments beginning on November 30, 2024; and (iii) 760 shares, which will vest upon achievement of certain pre-established performance goals. |